Why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer? Clinical researchers at Princess Margaret Hospital (PMH) in Toronto, Canada believe they can now answer that baffling question.
For Low Risk Prostate Cancer, Personalized Monitoring An Option
Active surveillance may be a viable option for some men with prostate cancer. Regular tests and careful tracking of any changes in the patient’s disease risk over time are imperative to ensure good outcomes, according to researchers in Toronto presenting at the annual meeting of the American Urological Association (AUA).